Multidomain Intervention Trial for Preventing Cognitive Decline among Older Adults with Type 2 Diabetes: J-MIND-Diabetes

期刊论文
出版模式：

开放获取
发表日期：

2024年6月26日

查看全文

T. Sugimoto,
A. Araki,
H. Fujita,
K. Fujita,
K. Honda,
N. Inagaki,
T. Ishida,
J. Kato,
M. Kishi,
Y. Kishino,
K. Kobayashi,
K. Kouyama,
Y. Kuroda,
S. Kuwahata,
N. Matsumoto,
T. Murakami,
H. Noma,
J. Ogino,
M. Ogura,
M. Ohishi,
H. Shimada,
K. Sugimoto,
T. Takenaka,
Y. Tamura,
H. Tokuda,
K. Uchida,
H. Umegaki,
Takashi Sakurai

摘要

Background

No multidomain intervention trials have been designed for the prevention of cognitive decline in older adults with type 2 diabetes.

Objectives

To investigate the efficacy of a multidomain intervention in preventing cognitive decline in older adults with type 2 diabetes and cognitive impairment.

Design

Eighteen-month, multi-centered, randomized controlled trial.

Setting

Twelve hospitals in Japan.

Participants

Outpatients with type 2 diabetes aged 70–85 years with cognitive impairment.

Intervention

The multidomain intervention program includes management of metabolic and vascular risk factors, exercise, nutritional counseling, and promotion of social participation. Participants in the control group received usual care and treatment for type 2 diabetes.

Measurements

The primary outcome was the change in a composite score combining several neuropsychological tests from baseline to the 18-month follow-up. To assess the differences in cognitive changes between the intervention and control groups, a mixed-effects model for repeated measures was used.

Results

Between March 13, 2019, and May 8, 2020, 361 participants were screened, and 154 were randomly assigned to either the intervention group (n = 81) or the control group (n = 73). Finally, 110 participants completed the trial. The between-group difference in the composite score changes was 0.068 (95% confidence interval, −0.091 to 0.226). Analyses for secondary outcomes indicated a positive impact of the intervention on memory and indicated that the intervention led to changes in dietary habits with increased intakes of niacin and meat, along with weight reduction compared to the control group.

Conclusion

The multidomain intervention did not demonstrate efficacy in preventing cognitive decline. However, this trial provided proof-of-concept evidence that multidomain interventions may offer cognitive benefits and contribute to changes in dietary behavior and weight reduction in older adults with type 2 diabetes and cognitive impairment. These findings should be confirmed in future studies.